Screener
MetLife MET Redeemable NCI
Redeemable NCI at other companies
Other financials
Where this comes from
Reported directly by MetLife in its filing.
Tagged under the XBRL concept us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount.
The source filing: MetLife’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:32 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001099219-26-000050
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total liabilities | 731,411 | 716,245 |
| Contingencies, Commitments and Guarantees (Note 18) | ||
| Mezzanine Equity | ||
| Redeemable noncontrolling interests | 220 | 241 |
| Equity | ||
| MetLife, Inc.’s stockholders’ equity: | ||
| Preferred stock, par value $0.01 per share; $2,905 aggregate liquidation preference | — | — |
| Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,196,795,831 and 1,195,587,190 shares issued, respectively; 637,752,080 and 655,333,773 shares outstanding, respectively | 12 | 12 |
Item 1. Financial Statements
FAQ
- What is MetLife's redeemable NCI?
- MetLife (MET) reported redeemable NCI of $220M in Q2 2026.
- What does redeemable NCI mean?
- Minority interests in subsidiaries that include a put option allowing the minority holder to require the parent to repurchase their stake.
Ask your AI about MetLife's redeemable nci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude